According to BusinesStat, in 2014, global sales of antibiotics amounted to 566.8 thousand tons, which is 23.5% higher than the 2010 level. Sales growth was promoted by the development of medical insurance in many countries around the world. Medical care is becoming more accessible to various segments of the population, which has a positive effect on sales of medicines, including antibiotics.
At the end of 2014, the largest share in the volume of sales of antibiotics accounted for the United States - 14.9% of the world total. The US leadership in sales is due to the Affordable Care Act. This law obliges all citizens to acquire health insurance. In some cases, insurance may be free for the insured person. The development of health insurance and a high population contribute to the high sales of antibiotics in the country.
It is expected that in 2015, the actual volume of sales of antibiotics will increase by 3.6% compared to 2014 and reach 587.3 thousand tons. Despite the deterioration of the economic situation in some countries of the world, the growth rate will be supported by expanding the production of generics, the output of pharmaceutical manufacturers to emerging markets, and the further development of health insurance.
Sales growth stimulates the production of antibiotics in the world. In 2014, their production volume increased by 8.1% compared to 2013 and amounted to 789.1 thousand tons. Production of antibiotics is considered a high risk business requiring significant investments. The main risk of manufacturers is the probability of the rapid emergence of resistance of microorganisms to the action of drugs. Nevertheless, the growth of production in the world is supported by stable demand for existing antibacterial agents.
“Analysis of the world market of antibiotics in 2010-2014, forecast for 2015-2019” includes the most important data necessary for understanding the current situation on the global market and assessing the prospects for its development:
Economy and population
Sales of antibiotics
External and internal trade in antibiotics
Import and export of antibiotics
Foreign trade prices of antibiotics
The review provides current data on more than 100 countries of the world and a forecast on the 25 leading countries of the world antibiotic market.
Leading countries: USA, China, Germany, France, Great Britain, India and other countries of the world.
The review provides details on import-export by types of antibiotics:
Pre-packaged for retail
Not packaged for retail
In preparing the review used statistical information:
United Nations Statistics Division
National Agencies and Compendia
International Trade Center
International Monetary Fund
Organization for Economic Cooperation and Development
World Trade Organization
Along with the official statistics, the review contains the results of BusinesStat research:
Analysis of open antibiotic market information
Survey of experts in the pharmaceutical industry
Categories: Consumer Products /.../ Medicines / Antibiotics
Industry /.../ Medicines / Antibiotics
The whole world